Crossmark

Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update

Published Online: 2021-01-07

Published Print: 2021-03

Authors

,

Korobelnik, Jean-François http://orcid.org/0000-0002-4438-9535
Loewenstein, Anat
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 26 November 2020

Revised: 26 November 2020

Accepted: 4 December 2020

First Online: 7 January 2021

Compliance with ethical standards

:

: Jean-François Korobelnik is a consultant for Allergan, Bayer, Kanghong, Novartis, and Roche. Anat Loewenstein is a consultant for Allergan, Bayer, Kanghong, Novartis, Roche, ForSight Labs, and Notal Vision.

Document is current